Use of isoxazole and crotonamide derivatives for the modulation of apoptosis

US6011051A · kind A · utility

Assignee

• Hoechst GmbH · DE

Inventors

• Stefan Mullner · Langenfeld, DE
• Claudia Dax · Gernsheim, DE

Key dates

• Filing date: Jul 23, 1997
• Grant date: Jan 4, 2000
• Expiry date: Jul 23, 2017

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of the formula I or II ##STR1## are suitable for the production of pharmaceuticals for the modulation of apoptosis. These compounds can be employed for the treatment of infarct, stroke, neurodegeneration or hypertrophic disorders.